Answer
Bexsero is indicated from 2 months of age for active immunisation against invasive meningococcal disease caused by Neisseria meningitidis group B, in accordance with official recommendations.
Sources for this answer
- Bexsero Meningococcal Group B vaccine for injection in pre-filled syringeGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated
Sources checked